Celldex Therapeutics, Inc.
Methods of inducing or enhancing an immune response comprising administering agonistic anti-CD40 antibodies
Last updated:
Abstract:
Isolated monoclonal agonistic antibodies which bind to human CD40 and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic and diagnostic methods for using the antibodies.
Status:
Grant
Type:
Utility
Filling date:
6 Aug 2020
Issue date:
9 Mar 2021